Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.
Type:
Grant
Filed:
July 17, 2018
Date of Patent:
March 19, 2019
Assignee:
PIMCO 2664 LIMITED
Inventors:
Lisa Patel, Stephen Allan Smith, Iain Robert Greig, Samuel Cameron Williams
Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.
Type:
Grant
Filed:
October 17, 2017
Date of Patent:
July 24, 2018
Assignee:
PIMCO 2664 Limited
Inventors:
Lisa Patel, Stephen Allan Smith, Iain Robert Greig, Samuel Cameron Williams
Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.
Type:
Grant
Filed:
December 16, 2015
Date of Patent:
June 26, 2018
Assignee:
PIMCO 2664 LIMITED
Inventors:
Stephen Allan Smith, Lisa Patel, Iain Robert Greig
Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.
Type:
Grant
Filed:
April 11, 2017
Date of Patent:
October 24, 2017
Assignee:
PIMCO 2664 LIMITED
Inventors:
Lisa Patel, Stephen Allan Smith, Iain Robert Greig, Samuel Cameron Williams
Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl -cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.
Type:
Grant
Filed:
June 24, 2014
Date of Patent:
April 18, 2017
Assignee:
PIMCO 2664 Limited
Inventors:
Lisa Patel, Stephen Allan Smith, Iain Robert Greig, Samuel Cameron Williams
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
Type:
Grant
Filed:
March 21, 2016
Date of Patent:
April 11, 2017
Assignee:
PIMCO 2664 Limited
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain substituted N-(4-hydroxy-4-methyl-cyclohexyl)-4-phenyl-benzenesulfonamide and N-(4-hydroxy-4-methyl-cyclohexyl)-4-(2-pyridyl)benzenesulfonamide compounds (collectively referred to herein as HMC compounds) that are useful, for example, in the treatment of disorders (e.g.
Type:
Application
Filed:
June 24, 2014
Publication date:
May 26, 2016
Applicant:
Pimco 2664 Limited
Inventors:
Lisa Patel, Stephen Allan Smith, Iain Robert Greig, Samuel Cameron Williams
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
Type:
Grant
Filed:
May 22, 2015
Date of Patent:
April 5, 2016
Assignee:
PIMCO 2664 LIMITED
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
Type:
Grant
Filed:
August 21, 2014
Date of Patent:
June 9, 2015
Assignee:
PIMCO 2664 Limited
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
Type:
Grant
Filed:
May 3, 2013
Date of Patent:
September 2, 2014
Assignee:
PIMCO 2664 Limited
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
Type:
Application
Filed:
May 3, 2013
Publication date:
September 19, 2013
Applicant:
PIMCO 2664 LIMITED
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl sulfonamides and related compounds (collectively referred to herein as ‘BPSAAA compounds’), as described herein, and including, for example, biphenyl-4-sulfonic acid (hydroxyalkyl-phenyl)-amides and related compounds.
Type:
Grant
Filed:
March 20, 2008
Date of Patent:
September 3, 2013
Assignee:
PIMCO 2664 Limited
Inventors:
Iain Robert Greig, Robert Jurgen Van't Hof, Stuart Hamilton Ralston
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
Type:
Grant
Filed:
September 18, 2009
Date of Patent:
May 7, 2013
Assignee:
PIMCO 2664 Limited
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”).
Type:
Grant
Filed:
September 18, 2009
Date of Patent:
June 26, 2012
Assignee:
PIMCO 2664 Limited
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-phenylene compounds of the following formula (I) (collectively referred to herein as “APSAP compounds”).
Type:
Application
Filed:
September 18, 2009
Publication date:
August 4, 2011
Applicant:
PIMCO 2664 LIMITED
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof
Abstract: The present invention pertains generally to the field of therapeutic compounds, and more specifically to certain aryl-phenyl-sulfonamido-cycloalkyl compounds of the following formula (collectively referred to herein as “APSAC compounds”).
Type:
Application
Filed:
September 18, 2009
Publication date:
July 14, 2011
Applicant:
PIMCO 2664 LIMITED
Inventors:
Iain Robert Greig, Rose Mary Sheridan, Raymond Fisher, Matthew John Tozer, Juha Andrew Clase, Andrew Smith, Andrew Robert Tuffnell, Robert Jurgen Van 't Hof